Search research articles
Contact Us
Filters
Showing results (31-40 of 38) with videos related to
Page
of 4
Sort By:
You have reached the last page of results.
This site can display upto 38 results.
The American Journal of Surgical Pathology
|
June 19, 2018
Ectomesenchymal Chondromyxoid Tumor: A Neoplasm Characterized by Recurrent RREB1-MKL2 Fusions
Brendan C Dickson, Cristina R Antonescu, Prokopios P Argyris, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 20, 2024
Radiotherapy Versus Transoral Robotic Surgery for Oropharyngeal Squamous Cell Carcinoma: Final Results of the ORATOR Randomized Trial
Anthony C Nichols, Julie Theurer, Eitan Prisman, et al.
The Lancet. Oncology
|
August 17, 2019
Radiotherapy versus transoral robotic surgery and neck dissection for oropharyngeal squamous cell carcinoma (ORATOR): an open-label, phase 2, randomised trial
Anthony C Nichols, Julie Theurer, Eitan Prisman, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 7, 2022
Randomized Trial of Radiotherapy Versus Transoral Robotic Surgery for Oropharyngeal Squamous Cell Carcinoma: Long-Term Results of the ORATOR Trial
Anthony C Nichols, Julie Theurer, Eitan Prisman, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology
|
May 10, 2024
Fit-for-Purpose Ki-67 Immunohistochemistry Assays for Breast Cancer
Emina E Torlakovic, Nick Baniak, Penny J Barnes, et al.
JAMA Oncology
|
April 28, 2022
Assessment of Toxic Effects and Survival in Treatment Deescalation With Radiotherapy vs Transoral Surgery for HPV-Associated Oropharyngeal Squamous Cell Carcinoma: The ORATOR2 Phase 2 Randomized Clinical Trial
David A Palma, Eitan Prisman, Eric Berthelet, et al.
BMC Cancer
|
February 16, 2020
Treatment de-escalation for HPV-associated oropharyngeal squamous cell carcinoma with radiotherapy vs. trans-oral surgery (ORATOR2): study protocol for a randomized phase II trial
Anthony C Nichols, Pencilla Lang, Eitan Prisman, et al.
Cell Reports
|
February 27, 2024
The genomic and evolutionary landscapes of anaplastic thyroid carcinoma
Peter Y F Zeng, Stephenie D Prokopec, Stephen Y Lai, et al.
Page
of 4
Search research articles
Search
Showing results (31-40 of 38) with videos related to
Sort By:
Page
of 4
You have reached the last page of results.
This site can display upto 38 results.
The American Journal of Surgical Pathology
|
June 19, 2018
Ectomesenchymal Chondromyxoid Tumor: A Neoplasm Characterized by Recurrent RREB1-MKL2 Fusions
Brendan C Dickson, Cristina R Antonescu, Prokopios P Argyris, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 20, 2024
Radiotherapy Versus Transoral Robotic Surgery for Oropharyngeal Squamous Cell Carcinoma: Final Results of the ORATOR Randomized Trial
Anthony C Nichols, Julie Theurer, Eitan Prisman, et al.
The Lancet. Oncology
|
August 17, 2019
Radiotherapy versus transoral robotic surgery and neck dissection for oropharyngeal squamous cell carcinoma (ORATOR): an open-label, phase 2, randomised trial
Anthony C Nichols, Julie Theurer, Eitan Prisman, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 7, 2022
Randomized Trial of Radiotherapy Versus Transoral Robotic Surgery for Oropharyngeal Squamous Cell Carcinoma: Long-Term Results of the ORATOR Trial
Anthony C Nichols, Julie Theurer, Eitan Prisman, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology
|
May 10, 2024
Fit-for-Purpose Ki-67 Immunohistochemistry Assays for Breast Cancer
Emina E Torlakovic, Nick Baniak, Penny J Barnes, et al.
JAMA Oncology
|
April 28, 2022
Assessment of Toxic Effects and Survival in Treatment Deescalation With Radiotherapy vs Transoral Surgery for HPV-Associated Oropharyngeal Squamous Cell Carcinoma: The ORATOR2 Phase 2 Randomized Clinical Trial
David A Palma, Eitan Prisman, Eric Berthelet, et al.
BMC Cancer
|
February 16, 2020
Treatment de-escalation for HPV-associated oropharyngeal squamous cell carcinoma with radiotherapy vs. trans-oral surgery (ORATOR2): study protocol for a randomized phase II trial
Anthony C Nichols, Pencilla Lang, Eitan Prisman, et al.
Cell Reports
|
February 27, 2024
The genomic and evolutionary landscapes of anaplastic thyroid carcinoma
Peter Y F Zeng, Stephenie D Prokopec, Stephen Y Lai, et al.
Page
of 4